Cumberland Pharmaceuticals Inc (CPIX) Insider Trading
- $323,419.49
- $835,932.32
- Dec. 21, 2022
- A J Kazimi
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Oct. 18, 2019 | CEO | 34 | $5.45 | Buy | $185.30 | |
Oct. 18, 2019 | Director | 50 | $5.48 | Buy | $274.00 | |
Oct. 16, 2019 | Director | 50 | $5.54 | Buy | $277.00 | |
Oct. 16, 2019 | CEO | 60 | $5.56 | Buy | $333.60 | |
Oct. 14, 2019 | Director | 50 | $5.65 | Buy | $282.50 | |
Oct. 14, 2019 | CEO | 60 | $5.67 | Buy | $340.20 | |
Oct. 11, 2019 | CEO | 60 | $5.71 | Buy | $342.60 | |
Oct. 10, 2019 | Director | 50 | $5.78 | Buy | $289.00 | |
Oct. 9, 2019 | CEO | 60 | $5.78 | Buy | $346.80 | |
Oct. 8, 2019 | Director | 50 | $5.79 | Buy | $289.50 | |
Oct. 7, 2019 | CEO | 60 | $5.74 | Buy | $344.40 | |
Oct. 4, 2019 | CEO | 60 | $5.76 | Buy | $345.60 | |
Oct. 4, 2019 | Director | 50 | $5.75 | Buy | $287.50 | |
Oct. 2, 2019 | CEO | 60 | $5.77 | Buy | $346.20 | |
Oct. 1, 2019 | Director | 50 | $5.83 | Buy | $291.50 | |
Sept. 30, 2019 | CEO | 60 | $5.89 | Buy | $353.40 | |
Sept. 27, 2019 | Director | 65 | $5.76 | Buy | $374.40 | |
Sept. 27, 2019 | CEO | 60 | $5.76 | Buy | $345.60 | |
Sept. 25, 2019 | CEO | 60 | $5.38 | Buy | $322.80 | |
Sept. 25, 2019 | Director | 3,470 | $5.31 | Sell | $18,425.70 | |
Sept. 23, 2019 | Director | 4,400 | $5.27 | Sell | $23,188.00 | |
Sept. 23, 2019 | CEO | 60 | $5.35 | Buy | $321.00 | |
Sept. 20, 2019 | CEO | 60 | $5.33 | Buy | $319.80 | |
Sept. 20, 2019 | Director | 3,700 | $5.31 | Sell | $19,647.00 | |
Sept. 18, 2019 | CEO | 120 | $4.93 | Buy | $591.60 | |
Sept. 18, 2019 | Director | 130 | $4.93 | Buy | $640.90 | |
Sept. 16, 2019 | CEO | 60 | $4.97 | Buy | $298.20 | |
Sept. 16, 2019 | Director | 65 | $4.97 | Buy | $323.05 | |
Sept. 13, 2019 | CEO | 120 | $5.18 | Buy | $621.60 | |
Sept. 13, 2019 | Director | 130 | $5.18 | Buy | $673.40 | |
Sept. 11, 2019 | CEO | 60 | $5.02 | Buy | $301.20 | |
Sept. 11, 2019 | Director | 2,700 | $5.01 | Sell | $13,527.00 | |
Sept. 9, 2019 | CEO | 60 | $5.19 | Buy | $311.40 | |
Sept. 9, 2019 | Director | 2,300 | $5.24 | Sell | $12,052.00 | |
Sept. 6, 2019 | CEO | 120 | $4.91 | Buy | $589.20 | |
Sept. 6, 2019 | Director | 400 | $4.91 | Sell | $1,964.00 | |
Sept. 4, 2019 | Director | 65 | $4.79 | Buy | $311.35 | |
Sept. 4, 2019 | CEO | 60 | $4.79 | Buy | $287.40 | |
Aug. 30, 2019 | Director | 3,100 | $5.16 | Sell | $15,996.00 | |
Aug. 29, 2019 | CEO | 120 | $5.04 | Buy | $604.80 | |
Aug. 27, 2019 | CEO | 120 | $5.19 | Buy | $622.80 | |
Aug. 27, 2019 | Director | 130 | $5.19 | Buy | $674.70 | |
Aug. 23, 2019 | Director | 65 | $5.38 | Buy | $349.70 | |
Aug. 23, 2019 | CEO | 60 | $5.38 | Buy | $322.80 | |
Aug. 21, 2019 | Director | 6,309 | $5.46 | Sell | $34,447.14 | |
Aug. 21, 2019 | CEO | 60 | $5.49 | Buy | $329.40 | |
Aug. 19, 2019 | CEO | 60 | $5.51 | Buy | $330.60 | |
Aug. 19, 2019 | Director | 1,000 | $5.45 | Sell | $5,450.00 | |
Aug. 16, 2019 | CEO | 120 | $5.62 | Buy | $674.40 | |
Aug. 15, 2019 | Director | 78 | $5.75 | Sell | $448.50 |
Insiders are both buying and selling Cumberland Pharmaceuticals Inc stock.
The insider traders at Cumberland Pharmaceuticals Inc are: A J Kazimi, Joseph C Galante, Martin E Cearnal, Kenneth Krogulski, Gordon R Bernard, Caroline Young, A J. Kazimi, Joey A Jacobs, Martin E. Cearnal, Michael Bonner, Thomas R Lawrence, Gordon R. Bernard, James Jones, Thomas Lawrence, and Thomas R. Lawrence
The most active insider trader at Cumberland Pharmaceuticals Inc is A J Kazimi with 130 trades.
Gordon R Bernard has sold the most Cumberland Pharmaceuticals Inc stock with a total value of $501,378.02.
Joey A Jacobs has bought the most Cumberland Pharmaceuticals Inc stock with a total value of $97,323.63.
The most recent insider trade for Cumberland Pharmaceuticals Inc was on Dec. 21, 2022.
The single biggest insider buy for Cumberland Pharmaceuticals Inc was from Kenneth Krogulski with a total value of $24,915.00 on Nov. 20, 2017.
The single biggest insider sell for Cumberland Pharmaceuticals Inc was from Thomas Lawrence with a total value of $90,800.00 on March 19, 2014.